Report Overview:
Obesity is a major health problem worldwide responsible for increased morbidity/mortality and high cost for the society. Management of obesity requires multidisciplinary approaches including diet, food supplement, exercise, behavior change, drug, medical device, gut microbiome manipulation, and surgery. Anti-obesity medical devices are an option for subjects who have not responded to more conservative medical treatments but want an alternative to surgery.
This report provides a deep insight into the global Obesity Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
Market Value:
The global Obesity Treatment market size was estimated at USD 5452.10 million in 2023 and is projected to reach USD 16907.57 million by 2032, exhibiting a CAGR of 13.40% during the forecast period.
By Types:
• Surgical & Implant Devices
• Medication Therapy
• Dietary
By Applications:
Children
Adults
Key players include:
• NutriSystem
• Inc. (U.S.)
• Kellogg Company (U.S.)
• Ethicon
• Inc. (U.S.)
• Medtronic (U.S.)
• Including or Excluding key companies relevant to your analysis.
